Page 53 - IMR ANNUAL REPORT 2021: INSTITUTE FOR MEDICAL RESEARCH

40 IMR ANNUAL REPORT 2021

Identification and
Characterisation of Mycobacterial
11 LysM Domains Towards the NMRR-20-533-53776 Dr Azura Mohd Nor
Development of Novel Anti-TB
Drugs
Profiling Carbohydrates and
Fatty Acids and Detection
of Immunoreactivity of
12 NMRR-19-3479-50901 Tay Bee Yong
Lipopolysaccharides (LPS) in
Three Leptospira Species with
Different Levels of Pathogenicity
Nasopharyngeal Carriage of Dr Fairuz Amran
Streptococcus pneumoniae in NMRR-19-3887-52245
13
INFECTIOUS DISEASES RESEARCH CENTRE (IDRC) 14 Study of Emerging Food-Borne NMRR-17-1134-36250 Nurhainis Ogu Salim
Healthy Population in Malaysia
Trematodiases in Tuaran and
Tambunan Districts, Sabah and

Field Evaluation of Sterile Insect
15 Its Impact on Public Healthcare NMRR-17-2652-39099 Dr Nazni Wasi Ahmad
for Aedes aegypti Suppression
Effectiveness of Novel Tools
for Integrated Vector Control Dr Nurulhusna Ab
16 Management on the Incidence NMRR-18-636-39710
of Dengue in Malaysia: a Cluster Hamid
Randomised Trial

Evaluation of Potential Antiviral
17 Activity of Ravidasvir Against NMRR-19-3150-51531 Dr Jeevanathan A/L
Dengue Virus (DENV) Kalyanasundram
Isolation and Propagation of
18 COVID-19 Virus (SARS CoV-2) in NMRR-20-709-54523 Dr Siti Nur Zawani
Selected Mammalian Cell Lines Rosli
Generation of Immune Fab
Dr Mohammad
19 Phage Display Library Against a NMRR-17-3569-34314 Ridhuan Mohd Ali
Novel Coronavirus (2019-nCoV)
In Vitro Susceptibility Pattern of
Aspergillus spp. and Fusarium
20 NMRR-20-207-53067 Dr Tan Xue Ting
spp. Against Commonly Used
Antifungal Agents in Malaysia
Development of Rapid Antigen Jama'ayah Mohamed
21 NMRR-20-944-54859
Detection of SARS-CoV-2 Zahidi@Ahmad Bakri
Development of Inactivated Dr Rozainanee Mohd
22 NMRR-20-1956-55005
COVID-19 Vaccine Zain
Identification of ACE2 and
TMPRSS2 Polymorphisms in
23 Malaysian COVID-19 Patients NMRR-20-1406-55175 Zarina Mohd Zawawi
and its Association with Disease
Severity